Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 25 entries
View as:

Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae

Phase: N/A Priority: Normal
NCT ID: NCT05293873 Org: User:
Start: 04/01/21 End: 06/30/23 Due: 06/30/24

Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT03346967 Org: User:
Start: 11/01/17 End: 03/30/20 Due: 03/30/21

Autologous BMNC Infusion for Liver Cirrhosis in Children With BA

Phase: N/A Priority: Normal
NCT ID: NCT05517317 Org: User:
Start: 01/01/15 End: 05/30/22 Due: 05/30/23

Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia

Phase: N/A Priority: Normal
NCT ID: NCT03468699 Org: User:
Start: 01/02/17 End: 10/31/21 Due: 10/31/22

Convalescent Plasma for COVID-19 Patients (CPCP)

Phase: N/A Priority: Normal
NCT ID: NCT04521036 Org: User:
Start: 12/01/20 End: 07/30/21 Due: 07/30/22

Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT05331872 Org: User:
Start: 11/01/20 End: 09/30/23 Due: 09/30/24

Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03343782 Org: User:
Start: 11/01/17 End: 08/01/19 Due: 08/01/20

Autologous Bone Marrow Stem Cell Therapy Combined With Psychological Therapy and Rehabilitation for Autism

Phase: N/A Priority: Normal
NCT ID: NCT03225651 Org: User:
Start: 07/18/17 End: 08/30/19 Due: 08/30/20

Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia

Phase: N/A Priority: Normal
NCT ID: NCT04522869 Org: User:
Start: 08/10/19 End: 10/25/21 Due: 10/25/22

Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty

Phase: N/A Priority: Normal
NCT ID: NCT04919135 Org: User:
Start: 10/19/21 End: 12/30/24 Due: 12/30/25

Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT05345418 Org: User:
Start: 04/01/22 End: 12/30/25 Due: 12/30/26

Autologous BMMNCs Combined With Educational Intervention for ASD

Phase: N/A Priority: Normal
NCT ID: NCT05307536 Org: User:
Start: 12/26/21 End: 07/30/23 Due: 07/30/24

Convalescent Plasma for COVID-19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04516954 Org: User:
Start: 08/01/20 End: 04/30/21 Due: 04/30/22

Stem Cell Infusion in the Treatment of Patients with Neurological Sequelae After Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT05292625 Org: User:
Start: 07/07/20 End: 11/30/23 Due: 11/30/24

Autologous Immune Enhancement Therapy (AIET) for Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05520372 Org: User:
Start: 01/01/16 End: 12/30/21 Due: 12/30/22

Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy from Brain Hypoxia: a Phase II Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT06629324 Org: User:
Start: 10/15/24 End: 01/31/27 Due: 01/31/28

Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05308836 Org: User:
Start: 05/04/21 End: 12/30/24 Due: 12/30/25

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06027957 Org: User:
Start: 08/02/23 End: 07/31/25 Due: 07/31/26

Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT04080921 Org: User:
Start: 06/16/14 End: 08/30/19 Due: 08/30/20

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia

Phase: N/A Priority: Normal
NCT ID: NCT04062136 Org: User:
Start: 03/01/19 End: 11/30/20 Due: 11/30/21

Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female

Phase: N/A Priority: Normal
NCT ID: NCT05329662 Org: User:
Start: 05/01/23 End: 12/30/25 Due: 12/30/26

Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50

Phase: N/A Priority: Normal
NCT ID: NCT06726538 Org: User:
Start: 10/01/23 End: 06/30/25 Due: 06/30/26

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT04433104 Org: User:
Start: 06/09/20 End: 12/25/22 Due: 12/25/23

Improvement in Gross Motor Function and Muscle Tone in Children With Cerebral Palsy Related to Neonatal Icterus

Phase: N/A Priority: Normal
NCT ID: NCT03123562 Org: User:
Start: 04/01/14 End: 10/31/16 Due: 10/31/17

Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida

Phase: N/A Priority: Normal
NCT ID: NCT05472428 Org: User:
Start: 07/01/16 End: 08/31/21 Due: 08/31/22